in-20260107-IR-856250798RAA: 856 IAC 1-43-1

TITLE 856 INDIANA BOARD OF PHARMACY Regulatory Analysis LSA Document #25-798 I. Description of Rule II. Fiscal Impact Analysis III. Impacted Parties IV. Changes in Proposed Rule 856 IAC 1-43-1 Adds scope of the rule. 856 IAC 1-43-2 Adds the definitions that apply to the rule as statutory references to avoid repeating statute. 856 IAC 1-43-3 Adds the provider qualifications to clarify who can prescribe or dispense hormonal contraceptives. This will ensure only the proper providers are prescribing the hormonal contraceptives. 856 IAC 1-43-4 Adds a statutory reference for the definition of hormonal contraception to avoid repeating statute. 856 IAC 1-43-5 Adds the method for prescribing and dispensing hormonal contraceptives to meet the statutory requirements and ensure proper prescribing techniques are used for hormonal contraceptives. 856 IAC 1-43-6 Establishes the procedures that pharmacists must follow when prescribing hormonal contraception including a determination of eligibility and an initial assessment of the patient. This will ensure the safe practice of prescribing hormonal contraceptives. 856 IAC 1-43-7 Adds a record keeping requirement to ensure patient history is properly maintained and documentation of prescriptions is kept. 856 IAC 1-43-8 Adds a requirement that the pharmacist shall offer to provide to the patient counseling about the therapy and lists what the counseling may include. This will ensure the patients know about the hormonal contraceptives and how they should be used. V. Benefit Analysis VI. Cost Analysis VII. Sources of Information VIII. Regulatory Analysis IX. Contact Information of Staff to Answer Substantive Questions Notice of First Public Comment Period: 20260107-IR-856250798FNA Notice of Determination Received: December 11, 2025